The CLSI M100-S19 document has recommended the disuse of vancomycin disks for staphylococci and informed that studies on the action of teicoplanin in disk-diffusion testing should be performed. We describe the comparison of two methods, disk diffusion and broth microdilution, for determining teicoplanin susceptibility in clinical isolates of staphylococci. Overall results showed an aggregation rate of 96.8%;
The class of glycopeptide antibiotics has two major representatives: teicoplanin and vancomycin. These antimicrobial agents are employed against beta lactam-resistant isolates, especially methicillin-resistant Staphylococcus aureus (MRSA) (8) . Vancomycin is widely used in the United States (8, 9) while teicoplanin is utilized at same rates as those of vancomycin in Europe (12) . The determination of susceptibility to glycopeptides became very important after the description of resistant enterococci (3) and staphylococci to such antimicrobials (1, 2, 13) . The Clinical and Laboratory Standards Institute (CLSI) annually updates the breakpoints recommended for susceptibility determination by disk diffusion and for minimal inhibitory concentration (MIC) for different antimicrobial agents and microorganisms. The M100-S19 (5) protocol removed the vancomycin disk breakpoint for staphylococci as well as described a recommendation concerning teicoplanin disk breakpoints (Note 21, p. 57):
"Teicoplanin disk diffusion breakpoints were not reevaluated concurrently with the reevaluation of vancomycin disk diffusion breakpoints during recent studies. Therefore, the ability of these teicoplanin breakpoints to differentiate Susceptibility tests were carried out as described by CLSI (4, The overall agreement between disk-diffusion and reference broth-microdilution tests was of 96.8%. All the discordant staphylococci samples (2 isolates; 3.2%) were identified as S.
epidermidis and showed minor errors, thus ensuring approval of the disk diffusion test for teicoplanin ( Figure 1 ).
The observed results can be viewed as an attempt to preserve disk diffusion as a method to determine teicoplanin susceptibility.
There are some limitations in this study though: the small number of teicoplanin-resistant staphylococci in this sample, which requires further studies, and the absence of molecular typing of the samples. Aiming to reduce the possibility of evaluating clonal samples, we observed some demographic and phenotypic features of the isolates in order to include samples that were representative for the whole hospital and showed different patterns of susceptibility to the antimicrobials (Table 1) . By considering these observations, our data suggest that the disk-diffusion method can be used to determine teicoplanin susceptibility against staphylococci, at least in this institution. Multicenter studies evaluating a larger number of isolates with established genetic relatedness are highly necessary to extend this conclusion to other institutions. Clinical isolates of S. aureus and S. epidermidis 
